Navigation Links
Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America
Date:2/10/2010

MOUNTAIN VIEW, Calif., Feb. 10 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation (NYSE: BVF), to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada.  AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system.  Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009.  Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.  

"We are very excited to be partnering our lead program with Biovail.  Their key strategic focus and their CNS commercial plans match our view of an ideal partner for AZ-004," said Thomas B. King, Alexza President and CEO.  "We believe that AZ-004, if approved, has the potential to change the treatment practices for acute agitation, as the only product able to meet both the patients' desire for quickly and comfortably gaining control of their agitation, and the clinicians' goal of rapidly and reliably calming an agitated patient.

"This agreement provides Biovail with a promising late-stage specialty CNS product," said Bill Wells, Biovail's Chief Executive Officer.  "In clinical studies conducted by Alexza, Staccato loxapine rapid
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Alexza to Announce 2009 Second Quarter Financial Results and Update Its Clinical Pipeline Status on Wednesday, August 5, 2009
2. A Random Act of Kindness Changes a Familys Life Forever as Alexzander Prados Wish to Walk is Granted at Abilities Expo
3. Alexza Announces Agreement to Acquire Symphony Allegro, Including All Rights to AZ-004, AZ-104 and AZ-002
4. Alexzas Corporate Presentation to be Webcast at the Piper Jaffray Fourth Annual Europe Conference
5. Alexzas Corporate Presentation to be Webcast at the Eighth Annual JMP Securities Research Conference
6. Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status
7. Alexzas Corporate Presentation to be Webcast at the Cowen & Company 29th Annual Health Care Conference
8. Alexza to Announce 2008 Financial Results and Update Its Clinical Pipeline on Tuesday, March 10, 2009
9. Alexza Pharmaceuticals Promotes Peter D. Noymer, PhD to Vice President, Product R&D
10. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
11. Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute ... one of the most complex and difficult-to-treat forms ... , Locally advanced pancreatic cancer has the lowest ... cumulative five-year survival rate of only 4 percent ... an option for patients because tumors often involve ...
(Date:7/22/2014)... 2014 The “Human Insulin Market ... Acting, Premixed), Modern Human Insulin (Rapid Acting, Long ... Novomix, Tresiba, Others) - Forecast to 2019” provides ... challenges, opportunities, current market trends, and strategies impacting ... estimates and forecasts of the revenue and share ...
(Date:7/22/2014)... Canadian, Oklahoma (PRWEB) July 22, 2014 ... rehab center, is located in the naturally tranquil and ... Eufaula. , Its location is ideal for both a ... host a traditional Independence Day display of fireworks. ... watch from the beach, while swimming in the lake, ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Atreo Services ... system service and support programs and accessories in booth ... Annual Conference & Technical Exhibition in Chicago, Ill., Aug. ... 6-inch pneumatic tube system carriers as well as its ... common brand-name hospital tube systems. In addition, representatives ...
(Date:7/22/2014)... July 22, 2014 Bramal LED announced that ... with Ed Begley Jr, airing later this year via Discovery ... viewers will learn about Bramal LED’s T-10 lamps, which provide ... consumption by up to 70 percent. Bramal LED’s T-10 lamps ... matter of seconds or on direct AC voltage, with no ...
Breaking Medicine News(10 mins):Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 2Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Narconon Arrowhead Holds Annual Firework Event 2Health News:Narconon Arrowhead Holds Annual Firework Event 3Health News:Atreo Services to Introduce Pneumatic Tube System Solutions at ASHE Annual Conference 2Health News:Bramal LED to be featured in Upcoming Episode of Innovations with Ed Begley, Jr. 2
... young patients to unnecessary radiation when they order 3-D ... 2-D imaging, suggests a paper published by University of ... the orthodontic community over if and when to use ... treatment planning, said Dr. Sunil Kapila, lead author of ...
... of Massachusetts Medical School (UMMS) and Lundbeck Inc. today ... a targeted therapy to slow or halt the progression ... there is no way to stop or reverse the ... by a triad of progressive motor, cognitive and emotional ...
... 27, 2011) A team of researchers led by ... Saban Research Institute of Children,s Hospital Los Angeles, determined that ... bone mineral density, or bone strength. Length of puberty ... mineral density leads to osteoporosis, resulting in bones becoming increasingly ...
... , FRIDAY, Jan. 28 (HealthDay News) -- ... been known to have difficulty showing empathy, and new ... the same emotional deficiency. The finding suggests that ... to treat frontal brain injury patients, said the researchers ...
... ischemic attack (TIA), sometimes known as a mini-stroke. New ... the American Heart Association shows these attacks may not be ... the brain. The stroke research team, led by ... Research Centre at Vancouver Coastal Health and the University of ...
... By Maureen Salamon HealthDay Reporter , THURSDAY, ... a new restaurant opening in his small Louisiana town, where ... But Burley, an assistant professor of sociology at Southeastern ... heaping helpings of flat-screened TVs -- one in every booth ...
Cached Medicine News:Health News:Powerful 3-D X-rays for kids in braces should be the exception, not the rule 2Health News:UMMS and Lundbeck to explore potential targeted therapy for Huntington's disease 2Health News:UMMS and Lundbeck to explore potential targeted therapy for Huntington's disease 3Health News:Researchers discover age of onset of puberty predicts adult osteoporosis risk 2Health News:Mini-strokes leave 'hidden' brain damage: Vancouver Coastal Health and UBC Research 2Health News:TV: A Sneaky Part of the Food Pyramid 2Health News:TV: A Sneaky Part of the Food Pyramid 3
(Date:7/22/2014)... , July 22, 2014  Based on its ... market, Frost & Sullivan recognizes Siemens Healthcare with ... Siemens Healthcare,s FREEZEit solution, which employs Siemens, MAGNETOM ... robust and motion-insensitive imaging. The solution,s sophistication and ... of body MRI imaging in the U.S. market. ...
(Date:7/22/2014)... MANCHESTER, England , July 22, 2014 ... AEX:PHIA) announced today that The Christie NHS Foundation Trust ... center, will join a consortium whose mission is to ... imaging (MRI) guided radiation therapy system. Such a system ... real-time visualization of cancer targets. "The ...
(Date:7/22/2014)...  A central New York ... Total Artificial Heart implant is home, discharged from ... Freedom® portable driver to wait for a matching ... from a Syracuse architectural hardware company, suffered from ... medications, an implantable defibrillator and a pacemaker. ...
Breaking Medicine Technology:Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 2Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 4The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3
... HARBIN, China , July 7 /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, ... and distributor of botanical products,bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced,that, ... on the NYSE Amex,Market under the ticker symbol "CBP". , ... On this occasion, ...
... , SOMERVILLE, N.J. , July 7 ... surgical care, announced today the introduction of ETHICON™ ... designed to achieve adjunctive hemostasis (stoppage of bleeding) ... leakage. The US Food and Drug Administration (FDA) ...
Cached Medicine Technology:Renhuang Begins Trading on NYSE Amex 2Renhuang Begins Trading on NYSE Amex 3Renhuang Begins Trading on NYSE Amex 4Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant 2Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: